Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
BMC Cancer
    September 2025
  1. SUN Y, Hou L, Zhao E
    Correction: Short-term outcomes of laparoscopic D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in distal gastric cancer patients with high body mass index.
    BMC Cancer. 2025;25:1420.
    >> Share

    August 2025
  2. GAO X, Li Z, Yuan J, Mei X, et al
    Comparison of short- and long-term outcomes among total laparoscopic, laparoscopic-assisted, and open total gastrectomies for advanced gastric cancer patients after neoadjuvant chemotherapy: a multicenter retrospective cohort study.
    BMC Cancer. 2025;25:1401.
    >> Share

  3. SHANSHAN W, Lian W, Lu D, Liping L, et al
    Best practices for home nutritional management in postoperative gastric cancer patients: an evidence summary.
    BMC Cancer. 2025;25:1399.
    >> Share

  4. ZHANG R, Chen X, Chen G, Zhao Z, et al
    Novel surveillance protocol for gastric cancer based on CEA: a high-volume multi-center study.
    BMC Cancer. 2025;25:1396.
    >> Share

  5. ZENG T, Ling X, Chen S, Yang J, et al
    Prognostic value of nutritional risk assessment indices in patients with digestive system tumors.
    BMC Cancer. 2025;25:1385.
    >> Share

  6. WU H, Shu W, Ding Y, Li Q, et al
    The immune signatures predict gastric/gastroesophageal junction cancer response to first-line anti-PD-1 blockade or chemotherapy.
    BMC Cancer. 2025;25:1369.
    >> Share

  7. YUE HY, Yang XT, Zhang JC, Zhou P, et al
    Impacts of omega-3 fatty acids intervention on immune functions and clinical outcomes in surgical gastric cancer patients: a systematic review and trial sequential meta-analysis.
    BMC Cancer. 2025;25:1366.
    >> Share

  8. WANG L, Yang F, Dong Q, Tung TH, et al
    Anti-PD-1 therapy achieves favorable outcome in gastric cancer combined with chronic hepatitis B.
    BMC Cancer. 2025;25:1354.
    >> Share

  9. ZHAI XM, Yang YQ, Lin L, Luo HC, et al
    CircMORC1 downregulated in plasma EVs promotes gastric cancer cell proliferation and invasion via miR-103a-1-5p sponging.
    BMC Cancer. 2025;25:1313.
    >> Share

  10. HUANG Y, Huang Z, Hou W, Wang C, et al
    Cachexia index as a biomarker for cancer cachexia and quality of life in patients with gastric cancer.
    BMC Cancer. 2025;25:1293.
    >> Share

  11. LUAN X, Han X, Wang Z, Zhao L, et al
    Heterogeneity of metastatic gastric cancer: solitary non-regional lymph node metastasis and solitary lung metastasis showed better survival outcomes than other metastatic patterns.
    BMC Cancer. 2025;25:1287.
    >> Share

  12. XIA S, Xia Y, Liu T, Luo Y, et al
    Application of deep learning models in gastric cancer pathology image analysis: a systematic scoping review.
    BMC Cancer. 2025;25:1257.
    >> Share

    July 2025
  13. LIN CR, Wang MX, Guo XY, Huang YX, et al
    Global trends and sociodemographic inequalities in smoking and high-salt diet attributable to gastric cancer: a secondary analysis based on the global burden of disease 2021 study.
    BMC Cancer. 2025;25:1248.
    >> Share

  14. CHEN Y, Liu D, Wang Z, Lin Y, et al
    Machine learning-based dynamic CEA trajectory and prognosis in gastric cancer.
    BMC Cancer. 2025;25:1221.
    >> Share

  15. WEI J, Xue S, Du X, Dai Y, et al
    DNMT1 blocks SOX21-repressed CKS2 transcription to promote gastric cancer progression.
    BMC Cancer. 2025;25:1182.
    >> Share

  16. TANPRASERT P, Chakrabandhu B, Yodkeeree S, Dejkriengkraikul Limtrakul P, et al
    Survival benefit of conversion surgery after intravenous 5-fluorouracil-based chemotherapy in unresectable advanced gastric cancer: a retrospective cohort study.
    BMC Cancer. 2025;25:1160.
    >> Share

  17. YANG L, Zhang Q, Zhang H, Shi H, et al
    Nutrition impact symptoms as prognostic indicators in gastric cancer: the role of quality of life and survival outcomes.
    BMC Cancer. 2025;25:1037.
    >> Share

  18. GUO F, Wang D, Zhang L, Fang Y, et al
    Efficacy and safety of anti-PD-1 antibodies plus small molecule anti-angiogenic drugs and chemotherapy in gastric cancer peritoneal metastasis: a multicenter real-world study.
    BMC Cancer. 2025;25:1028.
    >> Share

  19. YANG J, Xu W, Wang S, Yu Z, et al
    Comprehensive multi-omics pan-cancer analysis revealed EGFLAM as a potential prognostic and immune infiltration-associated biomarker.
    BMC Cancer. 2025;25:1109.
    >> Share

  20. HUANG Y, Hu Y
    Impact of helicobacter pylori infection on the efficacy of ICIs in gastric cancer.
    BMC Cancer. 2025;25:1101.
    >> Share

  21. CHEN Q, Yao Z, Duan J, Zhang Y, et al
    The levels of plasma MiR-9 and MiR-106a are associated with the development of peritoneal carcinomatosis in patients with gastric cancer.
    BMC Cancer. 2025;25:1090.
    >> Share

    June 2025
  22. MA Y, Li Y, Lin Z, Wang J, et al
    Safety and efficacy of systemic chemotherapy plus PD-1 inhibitor in combination with intravenous or intraperitoneal bevacizumab in gastric cancer with peritoneal metastasis.
    BMC Cancer. 2025;25:1010.
    >> Share

  23. TUOHUTI T, Abulizi K, Li T
    Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:1002.
    >> Share

  24. WANG Y, Li Y, Guo Y, Jiang S, et al
    Lipid accumulation product and visceral adiposity index as independent predictors of long-term survival after gastric cancer immunotherapy.
    BMC Cancer. 2025;25:1009.
    >> Share

  25. SONG S, Zhang X, Cui P, He W, et al
    Plasma cfDNA multi-omic biomarkers profiling for detection and stratification of gastric carcinoma.
    BMC Cancer. 2025;25:1003.
    >> Share

  26. LAN N, Lai M, Gao Y, Wang X, et al
    The mediating role of postoperative blood glucose in the relationship between body composition and overall survival in non-diabetic gastric cancer patients.
    BMC Cancer. 2025;25:995.
    >> Share

  27. WU YY, Lee LC, Zeng H, Gu Y, et al
    Synergistic effects of PD-1 antibody and chemotherapy followed by surgery-centric local treatment in patients with limited-metastatic gastric or gastroesophageal adenocarcinoma (ROSETTE trial): an open-label, single-center, randomized phase 2 trial.
    BMC Cancer. 2025;25:981.
    >> Share

    May 2025
  28. DU K, Hu W, Gao S, Gan J, et al
    Identification of multiomics and immune infiltration-associated biomarkers for early gastric cancer: a machine learning-based diagnostic model development study.
    BMC Cancer. 2025;25:972.
    >> Share

  29. ZHANG M, Bai L, Chen J, Meng Q, et al
    Clinical benefit of continuation of PD-1 inhibitors after progression on first-line chemoimmunotherapy in metastatic gastric cancer and biomarker exploration.
    BMC Cancer. 2025;25:935.
    >> Share

  30. ZHANG B, Chen Y, Gu X, Zheng Y, et al
    Fucosyltransferase 11 restrains ferroptosis via upregulation GPX4 expression in gastric cancer.
    BMC Cancer. 2025;25:923.
    >> Share

  31. LI H, Chen H, Zhao T, Zhang W, et al
    CD2AP shapes a stromal reduced tumor microenvironment and contributes to immunotherapy in gastric cancer.
    BMC Cancer. 2025;25:910.
    >> Share

  32. ZHANG C, Wang K, Zhang Z, Zhao X, et al
    Safety and short?term outcomes of a modified tubular esophagogastrostomy versus double tract reconstruction after proximal gastrectomy: a propensity score matching analysis.
    BMC Cancer. 2025;25:908.
    >> Share

  33. FAN S, Jiang H, Xu Q, Shen J, et al
    Risk factors for pneumonia after radical gastrectomy for gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2025;25:840.
    >> Share

  34. LING T, Zuo Z, Huang M, Ma J, et al
    Stacking classifiers based on integrated machine learning model: fusion of CT radiomics and clinical biomarkers to predict lymph node metastasis in locally advanced gastric cancer patients after neoadjuvant chemotherapy.
    BMC Cancer. 2025;25:834.
    >> Share

    April 2025
  35. RAFIEPOOR H, Banoei MM, Ghorbankhanloo A, Muhammadnejad A, et al
    Exploring the potential of machine learning in gastric cancer: prognostic biomarkers, subtyping, and stratification.
    BMC Cancer. 2025;25:809.
    >> Share

  36. LIU G, Cao S, Liu X, Tian Y, et al
    Effect of perioperative probiotic supplements on the short-term clinical outcomes of patients undergoing laparoscopic or robotic radical gastrectomy after neoadjuvant chemotherapy: Study protocol for a multicenter randomized controlled trial (GISSG202
    BMC Cancer. 2025;25:776.
    >> Share

  37. GUO H, Chen S, Zheng T, Ding P, et al
    Association of low skeletal muscle mass and radiodensity with clinical outcomes in patients undergoing robotic radical gastric cancer surgery: a population-based retrospective cohort study.
    BMC Cancer. 2025;25:741.
    >> Share

  38. BU S, Wang S, Wang T, Xing H, et al
    Efficacy and safety of XELOX combined with neoadjuvant radiotherapy versus neoadjuvant chemotherapy in locally advanced gastric cancer.
    BMC Cancer. 2025;25:731.
    >> Share

  39. FU M, Wang X, Zhou J, Wang J, et al
    Incidence and risk factors of sarcopenia in gastric cancer patients: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:711.
    >> Share

  40. WU GF, He CH, Xi WT, Zhai WB, et al
    Sarcopenia defined by the global leadership initiative in sarcopenia (GLIS) consensus predicts adverse postoperative outcomes in patients undergoing radical gastrectomy for gastric cancer: analysis from a prospective cohort study.
    BMC Cancer. 2025;25:679.
    >> Share

  41. BABA K, Suzuki N, Imamura CK, Booka E, et al
    A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer.
    BMC Cancer. 2025;25:675.
    >> Share

  42. ZHANG C, Wang T, Yuan J, Wang T, et al
    Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.
    BMC Cancer. 2025;25:674.
    >> Share

  43. SHAO Y, Chen C, Yu X, Yan J, et al
    Comprehensive analysis of scRNA-seq and bulk RNA-seq data via machine learning and bioinformatics reveals the role of lysine metabolism-related genes in gastric carcinogenesis.
    BMC Cancer. 2025;25:644.
    >> Share

  44. NASCA V, Bergamo F, Foltran L, Antonuzzo L, et al
    Adjuvant TRastuzumab deruxtecan plus fluoropyrimidine versus standard chemotherapy in HER2-positive gastric or gastroesophageal cancer patients with persistence of minimal residual disease in liquid biopsy after pre-operative chemotherapy and radical
    BMC Cancer. 2025;25:633.
    >> Share

  45. KONG PF, Yan YH, Duan YT, Fang YT, et al
    Comparative genomic analysis of Helicobacter pylori isolates from gastric cancer and gastritis in China.
    BMC Cancer. 2025;25:628.
    >> Share

  46. MA GF, Huang YY, Chen YC, Luo Z, et al
    Premature death patterns and trends of stomach cancer in Pudong, Shanghai: a population based study.
    BMC Cancer. 2025;25:618.
    >> Share

  47. XIN X, Tang Y, Lu M, Huang J, et al
    Prognostic value of diffusion-weighted imaging to cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for patients with gastric cancer and peritoneal metastases.
    BMC Cancer. 2025;25:616.
    >> Share

  48. ZHOU K, Hu X, Yang X, Wu Y, et al
    Clinicopathologic characteristics and prognostic factors of pure gastric neuroendocrine carcinoma patients undergoing radical surgery.
    BMC Cancer. 2025;25:606.
    >> Share

  49. SUN Y, Wen L, Xiang W, Luo X, et al
    Added value of pretreatment CT-based Node-RADS score for predicting survival outcome of locally advanced gastric cancer: compared with clinical N stage.
    BMC Cancer. 2025;25:598.
    >> Share

    March 2025
  50. WU Z, Wang X, Shi S, Kong D, et al
    Heterogeneity of T cells regulates tumor immunity mediated by Helicobacter pylori infection in gastric cancer.
    BMC Cancer. 2025;25:567.
    >> Share

  51. LAN Y, Sun W, Zhong S, Xu Q, et al
    A risk prediction model for gastric cancer based on endoscopic atrophy classification.
    BMC Cancer. 2025;25:518.
    >> Share

  52. HE QC, Huang ZN, Lv CB, Wu YH, et al
    Effect of Helicobacter pylori infection on survival outcomes of patients undergoing radical gastrectomy after neoadjuvant chemotherapy: a multicenter study in China.
    BMC Cancer. 2025;25:460.
    >> Share

  53. GAN X, Jia Y, Shan F, Ying X, et al
    Comprehensive evaluation of tumor response better evaluates the efficacy of neoadjuvant chemotherapy and predicts the prognosis in gastric cancer - a post hoc analysis of a single-center randomized controlled trial.
    BMC Cancer. 2025;25:401.
    >> Share

  54. KANWAL W, Narjis K, Musani S, Nancy F, et al
    Exploring Zanidatamab's efficacy across HER2-positive Malignancies: a narrative review.
    BMC Cancer. 2025;25:382.
    >> Share

    February 2025
  55. XU M, Zhang Y, Zhao K, Jiang H, et al
    Prediction of pathological response to neoadjuvant immunochemotherapy with baseline and post-treatment (18)F-FDG PET imaging biomarkers in patients with locally advanced gastric cancer.
    BMC Cancer. 2025;25:378.
    >> Share

  56. WANG L, Chang Y, Ma J, Qu W, et al
    Identifying high-risk candidates for prolonging progression-free survival in primary gastric carcinoma subject to "double invasion": an analytical approach utilizing lasso-cox regression.
    BMC Cancer. 2025;25:381.
    >> Share

  57. PAN H, Sun H, Zuo Y, Zhao R, et al
    The prealbumin-CD19(+) index predicts surgical survival in patients with GC.
    BMC Cancer. 2025;25:359.
    >> Share

  58. QIAO Y, Kang B, Zhang Y, Song J, et al
    Short- and long-term outcomes of robotic- versus laparoscopic-assisted early-onset gastric cancer: a propensity score-matched retrospective cohort study.
    BMC Cancer. 2025;25:361.
    >> Share

  59. ENDO S, Higashida M, Fujiwara Y, Furuya K, et al
    Risk factors for postoperative pneumonia in older adults aged >/= 80 years with gastric cancer.
    BMC Cancer. 2025;25:342.
    >> Share

  60. SUN Y, Hou L, Zhao E
    Short-term outcomes of laparoscopic D2 lymphadenectomy versus D2 lymphadenectomy plus complete mesogastric excision in distal gastric cancer patients with high body mass index.
    BMC Cancer. 2025;25:329.
    >> Share

  61. GU Y, Ma X, Xin H, Xiang Z, et al
    Navigating life after gastric cancer surgery: a qualitative exploration of the dyadic patient-caregiver perspective on quality of life outcomes.
    BMC Cancer. 2025;25:288.
    >> Share

  62. XU T, Huang J, Lin J, Liu Y, et al
    Correction: Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression.
    BMC Cancer. 2025;25:292.
    >> Share

  63. OU JY, Liu Y, Zhang L, Luo TQ, et al
    Assessing the quality and integrating the evidence and strength of recommendations in the guidelines for gastric precancerous lesions.
    BMC Cancer. 2025;25:272.
    >> Share

  64. LI X, Ding P, Wu J, Wu H, et al
    Preoperative sarcopenia and postoperative accelerated muscle loss negatively impact survival after resection of locally advanced gastric cancer.
    BMC Cancer. 2025;25:269.
    >> Share

  65. YEKTAKOOSHALI MH, SobhZahedi M, Razavi Tousi SMT, Hamidi M, et al
    Correction: Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line modulating JAK2/STAT3/mTOR/PI3K pathway.
    BMC Cancer. 2025;25:258.
    >> Share

  66. XU T, Huang J, Lin J, Liu Y, et al
    Site-specific immunoglobulin G N-glycosylation is associated with gastric cancer progression.
    BMC Cancer. 2025;25:217.
    >> Share

  67. ZENG Y, Chen Y, Zhu D, Xu J, et al
    Machine learning assisted radiomics in predicting postoperative occurrence of deep venous thrombosis in patients with gastric cancer.
    BMC Cancer. 2025;25:220.
    >> Share

  68. HIRANO H, Takahashi N, Amanuma Y, Suzuki N, et al
    Phase II trial of nab-paclitaxel plus ramucirumab in combination with nivolumab for unresectable advanced or recurrent gastric cancer after progression on first-line treatment including fluoropyrimidine, platinum, and anti-PD-1/PD-L1 antibody (PADDLE)
    BMC Cancer. 2025;25:201.
    >> Share

  69. LI Y, Cao Y, Wang X, Li C, et al
    Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherap
    BMC Cancer. 2025;25:198.
    >> Share

  70. ZHANG XQ, Huang ZN, Wu J, Zheng CY, et al
    Development and validation of a prognostic prediction model for elderly gastric cancer patients based on oxidative stress biochemical markers.
    BMC Cancer. 2025;25:188.
    >> Share

    January 2025
  71. ZHONG B, Xiong Z, Zheng J, Mohamed SA, et al
    Impact of Helicobacter pylori infection on neoadjuvant chemotherapy in locally advanced gastric cancer: a retrospective analysis.
    BMC Cancer. 2025;25:157.
    >> Share

  72. YUAN J, Jiang Y, Chen F, Li T, et al
    Clinical implications of DNA ploidy, stroma, and nucleotyping in predicting peritoneal metastasis risk for gastric cancer.
    BMC Cancer. 2025;25:144.
    >> Share

  73. VARSHNEY N, Singh S, Kandpal M, Saini V, et al
    Interplay of aurora kinase a functional residues and Epstein-barr Nuclear Antigen 1 in Epstein-barr virus associated Gastric cancer using AGS cells.
    BMC Cancer. 2025;25:143.
    >> Share

  74. LI Y, Ma J, Cheng W
    Harnessing Machine Learning and Nomogram Models to Aid in Predicting Progression-Free Survival for Gastric Cancer Patients Post-Gastrectomy with Deficient Mismatch Repair(dMMR).
    BMC Cancer. 2025;25:141.
    >> Share

  75. NAJAFI S, Mohammadkhah F, Salemi SA, Kamyab A, et al
    The impact of educational intervention based on the theory of planned behavior on preventive behaviors for gastric cancer in obese and smoking individuals.
    BMC Cancer. 2025;25:129.
    >> Share

  76. SOWELL FG, de Milliano T, Brady KJS, Foglia G, et al
    A conceptual model for advanced/metastatic gastric or gastroesophageal junction cancer: a review of qualitative studies and results from patient interviews.
    BMC Cancer. 2025;25:88.
    >> Share

  77. XIAO Y, Zhu J, Xie H, Wang Z, et al
    Intratumoral and peritumoral radiomics for forecasting microsatellite status in gastric cancer: a multicenter study.
    BMC Cancer. 2025;25:66.
    >> Share

  78. YEKTAKOOSHALI MH, SobhZahedi M, Razavi Tousi SMT, Hamidi M, et al
    Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2/STAT3/mTOR/PI3K pathway.
    BMC Cancer. 2025;25:44.
    >> Share

  79. YIN C, Sun Y, Liang J, Sui X, et al
    Sedated and unsedated gastroscopy has no influence on the outcomes of patients with gastric cancer: a retrospective study.
    BMC Cancer. 2025;25:13.
    >> Share

  80. YU X, Shao Y, Dong H, Yan J, et al
    Molecular subtype of gastric cancer based on apoptosis-related genes reveals differential immune microenvironment and intratumoral microorganisms distribution.
    BMC Cancer. 2025;25:12.
    >> Share

    December 2024
  81. ZHANG YT, Wang SH, Zhao L, Wang HM, et al
    Screening and identification of vascular endothelial cell targeting peptide in gastric cancer through novel integrated in vitro and in vivo strategy.
    BMC Cancer. 2024;24:1595.
    >> Share

  82. IITAKA S, Kuroda A, Narita T, Hatakeyama H, et al
    Evaluation of N-NOSE as a surveillance tool for recurrence in gastric and esophageal cancers: a prospective cohort study.
    BMC Cancer. 2024;24:1544.
    >> Share

  83. MUDIYANSELAGE SB, Nguyen D, Tang B, Williams R, et al
    The epidemiological trends and predictions of esophageal squamous cell carcinoma and gastroesophageal junction carcinoma: an Australian population-based study.
    BMC Cancer. 2024;24:1498.
    >> Share

  84. LUO D, Xu H, Jiang C, Zheng J, et al
    Knowledge, attitudes, and practices of primary caregivers of gastric cancer patients regarding postoperative dietary management.
    BMC Cancer. 2024;24:1487.
    >> Share

  85. BRODKIN J, Kaprio T, Hagstrom J, Leppa A, et al
    Prognostic effect of immunohistochemically determined molecular subtypes in gastric cancer.
    BMC Cancer. 2024;24:1482.
    >> Share

    November 2024
  86. TIAN Y, Qiu S, Yang S, Jiang Y, et al
    The oncogenic role and prognostic value of PXDN in human stomach adenocarcinoma.
    BMC Cancer. 2024;24:1463.
    >> Share

  87. YU Z, Liang C, Li R, Xu Q, et al
    The impact of diabetes mellitus on short and long term outcomes in patients with gastric cancer following radical surgery: a retrospective cohort study with propensity score matching.
    BMC Cancer. 2024;24:1461.
    >> Share

  88. LIU SS, Wang JK, Liu MS, Guo DF, et al
    ILF2 protein is a promising serum biomarker for early detection of gastric cancer.
    BMC Cancer. 2024;24:1447.
    >> Share

  89. ABDI E, Latifi-Navid S, Kholghi-Oskooei V, Mostafaiy B, et al
    Roles of the lncRNAs MEG3, PVT1 and H19 tagSNPs in gastric cancer susceptibility.
    BMC Cancer. 2024;24:1440.
    >> Share

  90. ZHANG H, Yang W, Tan X, He W, et al
    Long-term relative survival of patients with gastric cancer from a large-scale cohort: a period-analysis.
    BMC Cancer. 2024;24:1420.
    >> Share

  91. MIYAMOTO H, Toyokawa T, Ishidate T, Kuroda K, et al
    Significance of the geriatric nutritional risk index and neutrophil-to-lymphocyte ratio as prognostic indicators in older patients with gastric cancer: a retrospective cohort study.
    BMC Cancer. 2024;24:1396.
    >> Share

  92. HE L, Gao X, Li T, Li X, et al
    Multicriteria optimization achieves superior normal tissue sparing in volumetric modulated arc therapy for gastric cancer.
    BMC Cancer. 2024;24:1376.
    >> Share

    October 2024
  93. LIU Y, Yang X, Wang Y, Xie S, et al
    Efficacy and safety of surufatinib in the treatment of patients with neuroendocrine tumor: a real-world study in Chinese population.
    BMC Cancer. 2024;24:1342.
    >> Share

  94. NIU X, Ma F, Li F, Wei C, et al
    Integration of bioinformatics and cellular experiments unveils the role of SYT12 in gastric cancer.
    BMC Cancer. 2024;24:1331.
    >> Share

  95. LIU YY, Tsai MY, Liu TT, Liu YW, et al
    The real-world efficacy and safety of nivolumab plus chemotherapy in patients with HER2-negative advanced gastric cancer.
    BMC Cancer. 2024;24:1325.
    >> Share

  96. SUN Y, Chen C, Hou L, Zhao E, et al
    Short-term outcomes and quality of life of esophagogastrostomy versus the double-tract reconstruction after laparoscopic proximal gastrectomy.
    BMC Cancer. 2024;24:1324.
    >> Share

  97. LI J, Ding F, Zhang S, Jia Y, et al
    Continuation of same programmed death-1 inhibitor regime beyond progression is a novel option for advanced gastric cancer.
    BMC Cancer. 2024;24:1292.
    >> Share

  98. YANG X, Zeng Z, Liao Z, Zhu C, et al
    Comparison of proximal gastrectomy and total gastrectomy in proximal gastric cancer: a meta-analysis of postoperative health condition using the PGSAS-45.
    BMC Cancer. 2024;24:1282.
    >> Share

    September 2024
  99. LIU F, Hu N, Jiang K, Liu H, et al
    Mutational signatures in 175 Chinese gastric cancer patients.
    BMC Cancer. 2024;24:1208.
    >> Share

  100. LIU ZK, Ma WX, Zhang JJ, Liu SD, et al
    Risk factor analysis and establishment of a predictive model for complications of elderly advanced gastric cancer with Clavien-Dindo classification >/= II grade.
    BMC Cancer. 2024;24:1185.
    >> Share

  101. ZHENG HL, Zhang LK, Lv CB, Xu BB, et al
    Impact of dynamic changes of tumor marker in neoadjuvant chemotherapy-treated triple-negative gastric cancer patients: a multi-center study.
    BMC Cancer. 2024;24:1188.
    >> Share

  102. FU L, Song L, Zhou X, Chen L, et al
    Serum metabolomics analysis of malnutrition in patients with gastric cancer: a cross sectional study.
    BMC Cancer. 2024;24:1195.
    >> Share

  103. LUAN X, Zhao L, Zhang F, Wang W, et al
    Sex disparity, prediagnosis lifestyle factors, and long-term survival of gastric cancer: a multi-center cohort study from China.
    BMC Cancer. 2024;24:1149.
    >> Share

  104. HE H, Dong K, Chen M, Wang Y, et al
    TOB1 inhibits the gastric cancer progression by focal adhesion pathway and ERK pathway based on transcriptional and metabolic sequencing.
    BMC Cancer. 2024;24:1130.
    >> Share

  105. INUKAI M, Nishi T, Matsuoka H, Matsuo K, et al
    Measurement of changes in serum-based inflammatory indicators to monitor response to nivolumab monotherapy in advanced gastric cancer: a multicenter retrospective study.
    BMC Cancer. 2024;24:1121.
    >> Share

  106. CHEN D, Tong W, Ang B, Bai Y, et al
    Revealing the crosstalk between LOX(+) fibroblast and M2 macrophage in gastric cancer by single-cell sequencing.
    BMC Cancer. 2024;24:1117.
    >> Share

  107. LUO D, Xu H, Jiang C, Zheng J, et al
    The prognostic role of palliative gastrectomy in advanced gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1096.
    >> Share

  108. GOKON Y, Nakashima Y, Ohki Y, Ogino T, et al
    Prognostic significance of low HER2 expression in gastric cancer: a retrospective, single-center analysis.
    BMC Cancer. 2024;24:1081.
    >> Share

    August 2024
  109. WANG Y, Lei X, Shan F, Li S, et al
    Long-term outcomes of laparoscopic versus open total gastrectomy in patients with advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study.
    BMC Cancer. 2024;24:1074.
    >> Share

  110. WANG Y, Li W, Zhou CM, Zhao Z, et al
    Mortality risk of patients with intestinal obstruction.
    BMC Cancer. 2024;24:1062.
    >> Share

  111. CHEN Z, Zhang G, Liu Y, Zhu K, et al
    Radiomics analysis in predicting vascular invasion in gastric cancer based on enhanced CT: a preliminary study.
    BMC Cancer. 2024;24:1020.
    >> Share

  112. JIANG X, Qin L, Hao Y, Yang Q, et al
    The staining results of early gastric cancer by indigo carmine chromoendoscopy associated with histological structure: a retrospective study.
    BMC Cancer. 2024;24:1015.
    >> Share

  113. DING P, Yang J, Wu J, Wu H, et al
    Combined systemic inflammatory immune index and prognostic nutrition index as chemosensitivity and prognostic markers for locally advanced gastric cancer receiving neoadjuvant chemotherapy: a retrospective study.
    BMC Cancer. 2024;24:1014.
    >> Share

  114. XU L, Liu J, An Y, Zhou L, et al
    Glycolysis-related genes predict prognosis and indicate immune microenvironment features in gastric cancer.
    BMC Cancer. 2024;24:979.
    >> Share

  115. XIAO H, Fu J, Liu R, Yan L, et al
    Gastric cancer cell-derived exosomal miR-541-5p induces M2 macrophage polarization through DUSP3/JAK2/STAT3 pathway.
    BMC Cancer. 2024;24:957.
    >> Share

    July 2024
  116. WU Q, Li T, Cui Y, Jiang H, et al
    Unveiling clinicopathologic features and outcomes for endoscopic submucosal dissection of early gastric cancer at gastric angulus in China.
    BMC Cancer. 2024;24:924.
    >> Share

    June 2024
  117. ZENG Z, Li Y, Zhou H, Li M, et al
    System-wide identification of novel de-ubiquitination targets for USP10 in gastric cancer metastasis through multi-omics screening.
    BMC Cancer. 2024;24:773.
    >> Share

  118. ENDO S, Higashida M, Furuya K, Yano S, et al
    Prognostic factors for gastric cancer patients aged >/= 85 years.
    BMC Cancer. 2024;24:745.
    >> Share

  119. YU M, Peng J, Lu Y, Li S, et al
    Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer.
    BMC Cancer. 2024;24:724.
    >> Share

  120. ICHIKAWA H, Usui K, Aizawa M, Shimada Y, et al
    Clinical application of targeted tumour sequencing tests for detecting ERBB2 amplification and optimizing anti-HER2 therapy in gastric cancer.
    BMC Cancer. 2024;24:719.
    >> Share

  121. ZHANG S, Xu H, Li W, Cui J, et al
    Development and validation of an inflammatory biomarkers model to predict gastric cancer prognosis: a multi-center cohort study in China.
    BMC Cancer. 2024;24:711.
    >> Share

  122. LI X, Wang C, Wang Y, Chen X, et al
    Integrated analysis of the role of PR/SET domain 14 in gastric cancer.
    BMC Cancer. 2024;24:685.
    >> Share

  123. YE J, Ying J, Chen H, Wu Z, et al
    PPIH acts as a potential predictive biomarker for patients with common solid tumors.
    BMC Cancer. 2024;24:681.
    >> Share

    May 2024
  124. WANG J, Lin J, Wang R, Tong T, et al
    Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:603.
    >> Share

  125. PANG H, Dai L, Chen L, Chen X, et al
    Prognostic value of the advanced lung cancer inflammation index in patients with gastric cancer after radical gastrectomy: a propensity-score matching cohort study and meta-analysis.
    BMC Cancer. 2024;24:583.
    >> Share

  126. CHE B, Yuan S, Zhang H, Zhai J, et al
    Causal inference between pernicious anemia and cancers: a bidirectional two-sample mendelian randomization analysis.
    BMC Cancer. 2024;24:586.
    >> Share

  127. WANG S, Zhang W, Wu X, Zhu Z, et al
    Comprehensive analysis of T-cell regulatory factors and tumor immune microenvironment in stomach adenocarcinoma.
    BMC Cancer. 2024;24:570.
    >> Share

    April 2024
  128. ZHAN Z, Chen B, Cheng H, Xu S, et al
    Identification of prognostic signatures in remnant gastric cancer through an interpretable risk model based on machine learning: a multicenter cohort study.
    BMC Cancer. 2024;24:547.
    >> Share

  129. CHOI Y, Lee J, Shin K, Lee JW, et al
    Integrated clinical and genomic models using machine-learning methods to predict the efficacy of paclitaxel-based chemotherapy in patients with advanced gastric cancer.
    BMC Cancer. 2024;24:502.
    >> Share

  130. TAN Y, Feng LJ, Huang YH, Xue JW, et al
    Correction: Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
    BMC Cancer. 2024;24:469.
    >> Share

  131. LIU SS, Wan QS, Lv C, Wang JK, et al
    Integrating trans-omics, cellular experiments and clinical validation to identify ILF2 as a diagnostic serum biomarker and therapeutic target in gastric cancer.
    BMC Cancer. 2024;24:465.
    >> Share

  132. LUNA J, Picker N, Wilke T, Lutz M, et al
    Real-world evidence of treatment patterns and survival of metastatic gastric cancer patients in Germany.
    BMC Cancer. 2024;24:462.
    >> Share

  133. LI F, Dou J, Wei L, Li S, et al
    Biomarkers of lipid metabolism in gastric cancer: a case control study.
    BMC Cancer. 2024;24:455.
    >> Share

  134. ZHONG Y, Xiao YY, Ye JY, Jian GL, et al
    Diagnostic efficacy of contrast-enhanced gastric ultrasonography in staging gastric cancer: a meta-analysis.
    BMC Cancer. 2024;24:422.
    >> Share

  135. ZHAN PC, Yang S, Liu X, Zhang YY, et al
    A radiomics signature derived from CT imaging to predict MSI status and immunotherapy outcomes in gastric cancer: a multi-cohort study.
    BMC Cancer. 2024;24:404.
    >> Share

    March 2024
  136. YOON C, Lu J, Jun Y, Suh YS, et al
    Retraction Note: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
    BMC Cancer. 2024;24:392.
    >> Share

  137. TAN Y, Feng LJ, Huang YH, Xue JW, et al
    Development and validation of a Radiopathomics model based on CT scans and whole slide images for discriminating between Stage I-II and Stage III gastric cancer.
    BMC Cancer. 2024;24:368.
    >> Share

  138. LIU D, Quan H, Ma M, Zhou H, et al
    Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study.
    BMC Cancer. 2024;24:344.
    >> Share

  139. CHEN Y, Chen X, Lin Y, Zhang S, et al
    Correction: Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.
    BMC Cancer. 2024;24:314.
    >> Share

  140. WANG J, Shao M, Hu H, Xiao W, et al
    Convolutional neural network applied to preoperative venous-phase CT images predicts risk category in patients with gastric gastrointestinal stromal tumors.
    BMC Cancer. 2024;24:280.
    >> Share

    February 2024
  141. ZHANG J, Wang L, Zhang S, Cao R, et al
    Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients.
    BMC Cancer. 2024;24:266.
    >> Share

  142. CHEN Y, Chen X, Lin Y, Zhang S, et al
    Oncological risk of proximal gastrectomy for proximal advanced gastric cancer after neoadjuvant chemotherapy.
    BMC Cancer. 2024;24:255.
    >> Share

  143. LIM SH, Lee KW, Kim JJ, Im HS, et al
    Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).
    BMC Cancer. 2024;24:252.
    >> Share

  144. LI ZZ, Yan XL, Zhang Z, Chen JL, et al
    Prognostic value of GLIM-defined malnutrition in combination with hand-grip strength or gait speed for the prediction of postoperative outcomes in gastric cancer patients with cachexia.
    BMC Cancer. 2024;24:253.
    >> Share

  145. DE MORAES FCA, Pasqualotto E, Chavez MP, Ferreira ROM, et al
    Efficacy and safety of Zolbetuximab plus chemotherapy for advanced CLDN18.2-positive gastric or gastro-oesophageal adenocarcinoma: a meta-analysis of randomized clinical trials.
    BMC Cancer. 2024;24:240.
    >> Share

  146. SUI H, Lou A, Li Z, Yang J, et al
    Retraction Note: Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.
    BMC Cancer. 2024;24:241.
    >> Share

  147. ZHENG HL, Wang FH, Zhang LK, Li P, et al
    Trajectories of neutrophil-to-lymphocyte ratios during neoadjuvant chemotherapy correlate with short- and long-term outcomes in gastric cancer: a group-based trajectory analysis.
    BMC Cancer. 2024;24:226.
    >> Share

  148. FARAMARZI S, Kiani B, Faramarzi S, Firouraghi N, et al
    Cancer patterns in Iran: a gender-specific spatial modelling of cancer incidence during 2014-2017.
    BMC Cancer. 2024;24:191.
    >> Share

    January 2024
  149. HONG Z, Wen P, Wang K, Wei X, et al
    The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
    BMC Cancer. 2024;24:141.
    >> Share

  150. WEI L, Wu X, Wang L, Chen L, et al
    Expression and prognostic value of APOBEC2 in gastric adenocarcinoma and its association with tumor-infiltrating immune cells.
    BMC Cancer. 2024;24:15.
    >> Share

  151. QU T, Zhang S, Yang S, Li S, et al
    Utilizing serum metabolomics for assessing postoperative efficacy and monitoring recurrence in gastric cancer patients.
    BMC Cancer. 2024;24:27.
    >> Share

    December 2023
  152. ZHU G, Cai H, Xiao Q, Zeng S, et al
    GRB7 plays a promoting role in the progression of gastric cancer.
    BMC Cancer. 2023;23:1262.
    >> Share

  153. CHE J, Zhao Y, Gu B, Li S, et al
    Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with the progression of gastroesophageal cancer.
    BMC Cancer. 2023;23:1238.
    >> Share

  154. NIE C, Xu W, Guo Y, Gao X, et al
    Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study.
    BMC Cancer. 2023;23:1239.
    >> Share

  155. GAO J, Lan J, Liao H, Yang F, et al
    Promising preclinical patient-derived organoid (PDO) and xenograft (PDX) models in upper gastrointestinal cancers: progress and challenges.
    BMC Cancer. 2023;23:1205.
    >> Share

  156. BOBRZYNSKI L, Sedlak K, Rawicz-Pruszynski K, Kolodziejczyk P, et al
    Evaluation of optimum classification measures used to define textbook outcome among patients undergoing curative-intent resection of gastric cancer.
    BMC Cancer. 2023;23:1199.
    >> Share

  157. JEON CH, Park KB, Lee H, Kim DJ, et al
    Refining gastric cancer staging: examining the interplay between number and anatomical location of metastatic lymph nodes - a retrospective multi-institutional study.
    BMC Cancer. 2023;23:1192.
    >> Share

    November 2023
  158. WEI C, He Y, Luo M, Chen G, et al
    The role of computed tomography features in assessing response to neoadjuvant chemotherapy in locally advanced gastric cancer.
    BMC Cancer. 2023;23:1157.
    >> Share

  159. ZHENG H, Yin X, Pan T, Tao X, et al
    Effect of different surgical approaches on the survival and safety of Siewert type II esophagogastric junction adenocarcinoma: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:1130.
    >> Share

  160. CHEN YY, Li BP, Wang JF, Wang Y, et al
    Investigating the prognostic and predictive value of the type II cystatin genes in gastric cancer.
    BMC Cancer. 2023;23:1122.
    >> Share

  161. LIU X, Ren J, Zhou R, Wen Z, et al
    Construction of iron metabolism-related prognostic features of gastric cancer based on RNA sequencing and TCGA database.
    BMC Cancer. 2023;23:1106.
    >> Share

  162. YANG Y, Li Y, Chen Z
    Impact of low serum iron on treatment outcome of PD-1 inhibitors in advanced gastric cancer.
    BMC Cancer. 2023;23:1095.
    >> Share

  163. TAKASHIMA Y, Komatsu S, Nishibeppu K, Ohashi T, et al
    A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer.
    BMC Cancer. 2023;23:1075.
    >> Share

    October 2023
  164. LUKSTA M, Bausys A, Bickaite K, Rackauskas R, et al
    Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study.
    BMC Cancer. 2023;23:1032.
    >> Share

  165. QYI YZ, Aung HH, Aye SN, Tung WS, et al
    Toll-like receptor 9 (-1237 T/C, -1486 T/C) and the risk of gastric cancer: a meta-analysis of genetic association studies.
    BMC Cancer. 2023;23:1027.
    >> Share

  166. SUN C, Niu P, Zhang X, Zhao L, et al
    Concurrent clinical and pathological response predicts favorable prognosis of patients with gastric cancer after neoadjuvant therapy: a real-world study.
    BMC Cancer. 2023;23:996.
    >> Share

  167. MAKUUCHI R, Terashima M, Terada M, Mizusawa J, et al
    Randomized controlled phase III trial to investigate superiority of robot-assisted gastrectomy over laparoscopic gastrectomy for clinical stage T1-4aN0-3 gastric cancer patients (JCOG1907, MONA LISA study): a study protocol.
    BMC Cancer. 2023;23:987.
    >> Share

  168. BEIHAGHI M, Sahebi R, Beihaghi MR, Nessiani RK, et al
    Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
    BMC Cancer. 2023;23:985.
    >> Share

  169. NARA K, Yamamoto T, Yamashita H, Yagi K, et al
    Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab the
    BMC Cancer. 2023;23:979.
    >> Share

  170. WU D, Lu J, Xue Z, Zhong Q, et al
    Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis.
    BMC Cancer. 2023;23:964.
    >> Share

  171. WANG Y, Guo Z, Tian Y, Cong L, et al
    MAPK1 promotes the metastasis and invasion of gastric cancer as a bidirectional transcription factor.
    BMC Cancer. 2023;23:959.
    >> Share

  172. XIANG L, Jin S, Yu Y, Wang D, et al
    Risk of venous thromboembolism in patients undergoing gastric cancer surgery: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:933.
    >> Share

  173. WANG Y, Pan J, An F, Chen K, et al
    GBP2 is a prognostic biomarker and associated with immunotherapeutic responses in gastric cancer.
    BMC Cancer. 2023;23:925.
    >> Share

  174. XIA B, Gu X, Xu T, Yan M, et al
    Exosomes-mediated transfer of LINC00691 regulates the formation of CAFs and promotes the progression of gastric cancer.
    BMC Cancer. 2023;23:928.
    >> Share

    September 2023
  175. KIM Y, Bae YJ, Kim JH, Kim H, et al
    Wnt/beta-catenin pathway is a key signaling pathway to trastuzumab resistance in gastric cancer cells.
    BMC Cancer. 2023;23:922.
    >> Share

  176. SUN Y, Chen C, Hou L, Zhao E, et al
    Short-term and long-term outcomes of patients with gastric cancer during versus before the COVID-19 pandemic: cohort study using propensity score matching method.
    BMC Cancer. 2023;23:913.
    >> Share

  177. WU J, Tian S, Xu J, Cheng N, et al
    Association of high-risk comorbidity with overall survival among patients with gastric cancer and its sex-specific differences in China: a retrospective observational cohort study.
    BMC Cancer. 2023;23:916.
    >> Share

  178. SAHIN MEH, Akbas F, Yardimci AH, Sahin E, et al
    The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer.
    BMC Cancer. 2023;23:911.
    >> Share

  179. MA X, Pierce E, Anand H, Aviles N, et al
    Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer.
    BMC Cancer. 2023;23:910.
    >> Share

  180. ZHAO L, Zhang F, Jiao F, Zhou X, et al
    The minimum number of examined lymph nodes was 24 for optimal survival of pathological T2-4 gastric cancer: a multi-center, hospital-based study covering 20 years of data.
    BMC Cancer. 2023;23:892.
    >> Share

    August 2023
  181. HIGUCHI S, Suehiro Y, Izuhara L, Yoshina S, et al
    BCL7B, a SWI/SNF complex subunit, orchestrates cancer immunity and stemness.
    BMC Cancer. 2023;23:811.
    >> Share

  182. DI Y, Ding L, Gao L, Huang H, et al
    Association of meat consumption with the risk of gastrointestinal cancers: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:782.
    >> Share

  183. SHIH YH, Lin HC, Liao PW, Chou CW, et al
    The efficacy of adjuvant chemotherapy for older adults with stage II/III gastric cancer: a retrospective cohort study.
    BMC Cancer. 2023;23:770.
    >> Share

  184. HAN Y, Wu J, Ji R, Tan H, et al
    Preoperative sarcopenia combined with prognostic nutritional index predicts long-term prognosis of radical gastrectomy with advanced gastric cancer: a comprehensive analysis of two-center study.
    BMC Cancer. 2023;23:751.
    >> Share

  185. TAKAHASHI N, Hara H, Nagashima K, Hirata K, et al
    Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophagogastric junction adenocarcinoma (RETRIEVE study, WJOG15822G).
    BMC Cancer. 2023;23:726.
    >> Share

    July 2023
  186. YOON C, Lu J, Jun Y, Suh YS, et al
    KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis.
    BMC Cancer. 2023;23:690.
    >> Share

  187. YANAGIMOTO Y, Imamura H, Adachi S, Odagiri K, et al
    The effect of specimen processing time on HER2 expression in gastric cancer and esophagogastric junction cancer: a single-center retrospective observational study.
    BMC Cancer. 2023;23:645.
    >> Share

    June 2023
  188. HAN Y, Wang X, Xu M, Teng Z, et al
    Aspartoacylase promotes the process of tumour development and is associated with immune infiltrates in gastric cancer.
    BMC Cancer. 2023;23:604.
    >> Share

  189. JEON CH, Park KB, Kim S, Seo HS, et al
    Predictive model for long-term weight recovery after gastrectomy for gastric cancer: an introduction to a web calculator.
    BMC Cancer. 2023;23:580.
    >> Share

  190. LORENZEN S, Schwarz A, Pauligk C, Goekkurt E, et al
    Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/I
    BMC Cancer. 2023;23:561.
    >> Share

  191. SHEN X, Liu H, Zhou H, Cheng Z, et al
    Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis.
    BMC Cancer. 2023;23:559.
    >> Share

  192. TIAN Y, Pang Y, Yang PG, Guo HH, et al
    Clinical implications of micro lymph node metastasis for patients with gastric cancer.
    BMC Cancer. 2023;23:536.
    >> Share

  193. E Y, Yu Q, Sun T, Xue H, et al
    The relationship between pepsinogen C and gastric carcinogenesis: a transgene and population study.
    BMC Cancer. 2023;23:520.
    >> Share

  194. LI Y, Wu G, Liu J, Zhang Y, et al
    Log odds of positive lymph nodes as a novel prognostic predictor for gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2023;23:523.
    >> Share

  195. DU Y, Yu X, Chang ET, Yin L, et al
    EBV antibody and gastric cancer risk: a population-based nested case-control study in southern China.
    BMC Cancer. 2023;23:521.
    >> Share

  196. ZHAO Z, Zhu Y
    FAP, CD10, and GPR77-labeled CAFs cause neoadjuvant chemotherapy resistance by inducing EMT and CSC in gastric cancer.
    BMC Cancer. 2023;23:507.
    >> Share

    May 2023
  197. LEONG E, Ong SK, Si-Ramlee KA, Naing L, et al
    Cancer incidence and mortality in Brunei Darussalam, 2011 to 2020.
    BMC Cancer. 2023;23:466.
    >> Share

  198. XU D, Liu X, Ke S, Guo Y, et al
    CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer.
    BMC Cancer. 2023;23:464.
    >> Share

  199. ZHANG H, Wang H, Ye L, Bao S, et al
    Comprehensive transcriptomic analyses identify KDM genes-related subtypes with different TME infiltrates in gastric cancer.
    BMC Cancer. 2023;23:454.
    >> Share

  200. HAMADA T, Higashi M, Yokoyama S, Akahane T, et al
    MALAT1 functions as a transcriptional promoter of MALAT1::GLI1 fusion for truncated GLI1 protein expression in cancer.
    BMC Cancer. 2023;23:424.
    >> Share

  201. YANG H, Wang JB, Wang XK, Fan JH, et al
    Association between type of drinking water and upper gastrointestinal cancer incidence in the Linxian General Population.
    BMC Cancer. 2023;23:397.
    >> Share

    April 2023
  202. LIU Y, Shen S, Yan Z, Yan L, et al
    Expression characteristics and their functional role of IGFBP gene family in pan-cancer.
    BMC Cancer. 2023;23:371.
    >> Share

  203. CUI Y, Yu Y, Zheng S, Ying J, et al
    Does resection after neoadjuvant chemotherapy of docetaxel, oxaliplatin, and S-1 (DOS regimen) benefit for gastric cancer patients with single non-curable factor? a multicenter, prospective cohort study (Neo-REGATTA).
    BMC Cancer. 2023;23:308.
    >> Share

    March 2023
  204. WANG H, Cui H, Yang X, Peng L, et al
    TUBA1C: a new potential target of LncRNA EGFR-AS1 promotes gastric cancer progression.
    BMC Cancer. 2023;23:258.
    >> Share

  205. YANG J, Li J, Deng Q, Chen Z, et al
    Effect of neoadjuvant chemotherapy combined with arterial chemoembolization on short-term clinical outcome of locally advanced gastric cancer.
    BMC Cancer. 2023;23:246.
    >> Share

  206. KAMIYA H, Komatsu S, Nishibeppu K, Ohashi T, et al
    Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction.
    BMC Cancer. 2023;23:218.
    >> Share

  207. ZHANG L, Wang W, Ge S, Li H, et al
    Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial.
    BMC Cancer. 2023;23:211.
    >> Share

    February 2023
  208. XIAO H, Bertwistle D, Khela K, Middleton-Dalby C, et al
    Global retrospective analysis of clinician- and patient-reported clinical characteristics and humanistic burden of patients with gastroesophageal cancers on first-line treatment.
    BMC Cancer. 2023;23:186.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016